Meng Wei (孟威)
Meng Wei (孟威)
Verified email at osumc.edu
Title
Cited by
Cited by
Year
MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer
R Cui, W Meng, HL Sun, T Kim, Z Ye, M Fassan, YJ Jeon, B Li, C Vicentini, ...
Proceedings of the National Academy of Sciences 112 (31), E4288-E4297, 2015
1302015
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma
W Meng, Z Ye, R Cui, J Perry, V Dedousi-Huebner, A Huebner, Y Wang, ...
Clinical cancer research 19 (19), 5423-5433, 2013
1022013
MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7
R Cui, T Kim, M Fassan, W Meng, HL Sun, YJ Jeon, C Vicentini, E Tili, ...
Oncotarget 6 (26), 21802, 2015
722015
Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues
W Meng, JP McElroy, S Volinia, J Palatini, S Warner, LW Ayers, ...
PloS one 8 (5), e64393, 2013
722013
The role of miRNAs in angiogenesis, invasion and metabolism and their therapeutic implications in gliomas
S Beyer, J Fleming, W Meng, R Singh, SJ Haque, A Chakravarti
Cancers 9 (7), 85, 2017
462017
miR-130a deregulates PTEN and stimulates tumor growth
H Wei, R Cui, J Bahr, N Zanesi, Z Luo, W Meng, G Liang, CM Croce
Cancer research 77 (22), 6168-6178, 2017
402017
Combined RASSF1A and RASSF2A promoter methylation analysis as diagnostic biomarker for bladder cancer
W Meng, A Huebner, A Shabsigh, A Chakravarti, T Lautenschlaeger
Molecular biology international 2012, 2012
342012
miR-196b-5p–mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer
G Liang, W Meng, X Huang, W Zhu, C Yin, C Wang, M Fassan, Y Yu, ...
Proceedings of the National Academy of Sciences 117 (8), 4347-4357, 2020
322020
In vitro study of combined cilengitide and radiation treatment in breast cancer cell lines
T Lautenschlaeger, J Perry, D Peereboom, B Li, A Ibrahim, A Huebner, ...
Radiation oncology 8 (1), 1-10, 2013
322013
Distribution of tumor-infiltrating immune cells in glioblastoma
E Orrego, CA Castaneda, M Castillo, LA Bernabe, S Casavilca, ...
CNS oncology 7 (4), CNS21, 2018
172018
MicroRNA biomarkers for patients with muscle-invasive bladder cancer undergoing selective bladder-sparing trimodality treatment
W Meng, J Efstathiou, R Singh, J McElroy, S Volinia, R Cui, A Ibrahim, ...
International Journal of Radiation Oncology* Biology* Physics 104 (1), 197-206, 2019
102019
酸度对胡敏酸与镉和锌离子络合反应的影响
刘保峰, 王强, 孟威, 魏世强
西南农业大学学报 27 (4), 451-455, 2005
92005
Lung adenocarcinoma microRNA-31 expression levels to predict lymph node metastasis and patient survival.
T Lautenschlaeger, W Meng, Z Ye, R Cui, J Perry, A Huebner, ...
Journal of Clinical Oncology 31 (15_suppl), 7573-7573, 2013
32013
A 6-gene signature for outcome prediction of grade II/III glioma.
T Lautenschlaeger, A Huebner, O Oehlke, TA Juratli, B Li, W Meng, ...
Journal of Clinical Oncology 32 (15_suppl), 2002-2002, 2014
12014
A novel miR-146a-POU3F2/SMARCA5 pathway regulates stemness and therapeutic response in glioblastoma
T Cui, EH Bell, J McElroy, K Liu, E Sebastian, B Johnson, PM Gulati, ...
Molecular Cancer Research 19 (1), 48-60, 2021
2021
CSIG-30. miR-146a INHIBITS TUMORIGENESIS AND INDUCES TEMOZOLOMIDE SENSITIVITY VIA AFFECTING CANCER STEM CELL PROPERTIES IN GBM
T Cui, E Hlavin Bell, J McElroy, K Liu, P Manchanda Gulati, B Johnson, ...
Neuro-Oncology 21 (Supplement_6), vi50-vi50, 2019
2019
CSIG-24. miR-575 IS ASSOCIATED WITH WORSE SURVIVAL OF GBM PATIENTS AND ACTS AS A NOVEL ONCOGENE THROUGH TARGETING p27/CDKN1B AND BLID/BRCC2
INMPM GLIOBLASTOMA
Neuro-Oncology, 2018
2018
GENE-27. GENOME-WIDE DNA METHYLATION PROFILING IN GRADE II AND III GLIOMAS REVEALS A SUBSET OF GENES WITH PROGNOSTIC SIGNIFICANCE CONTROLLED BY PROMOTER METHYLATION
W Meng, EH Bell, R Singh, J McElroy, I Popp, J Fleming, B Johnson, ...
Neuro-Oncology 20 (Suppl 6), vi109, 2018
2018
Histone H3 lysine 9 methyltransferase SUV39H1 is associated with clinical outcome of renal clear cell carcinoma patients
W Meng, R Cui, SJ Haque, CM Croce, A Chakravarti
Cancer Research 77 (13 Supplement), 1383-1383, 2017
2017
ATRT-06. BET INHIBITORS AND HDAC INHIBITORS WORK SYNERGISTICALLY IN TREATING MULTIPLE SUBTYPES OF ATYPICAL TERATOID/RHABDOID TUMOR
F Liu, M Li, L Zhang, Y Sui, W Jiang, W Meng, J Wang, J Ma, Y Tang
Neuro-oncology 19 (Suppl 4), iv2, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–20